Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trebananib in Advanced Angiosarcoma
NCT01623869Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Jul 2012
- Primary completion
- Sep 2014
- Modality
- Peptides, Antibody-Based Therapeutics, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of trebananib in angiosarcoma, sponsored by National Cancer Institute. Started Jul 2012; status: completed.
02
Drugs
trebananib
03
Conditions
angiosarcoma
Beyond the preview
Go deeper on NCT01623869.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01623869.